Market Research Industry Reports

Visioneering Technologies Inc (VTI) - Product Pipeline Analysis, 2018 Update

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Visioneering Technologies Inc (VTI) is a medical device company that offers ophthalmic solutions. The company develops a portfolio of technologies to address eye care issues such as presbyopia, myopia and astigmatism. Its technology includes myopia correction technology, silicone hydrogel material platform and intraocular lens technology. VTI offers products such as multifocal lens and sphere lens for presbyope and myopia correction. It conducts market research in the areas of contact lens consumer study, eye care practitioner study, multifocal lens market opportunity and multifocal lens potential, among others. The companys optical designs for contact lenses and in-eye products will provide solutions to under-penetrated market. VTI is headquartered in Alpharetta, Georgia, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Visioneering Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



List of Tables 3
List of Figures 3
Visioneering Technologies Inc Company Overview 4
Visioneering Technologies Inc Company Snapshot 4
Visioneering Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Visioneering Technologies Inc Pipeline Analysis Overview 6
Visioneering Technologies Inc - Key Facts 6
Visioneering Technologies Inc - Major Products and Services 7
Visioneering Technologies Inc Pipeline Products by Development Stage 8
Visioneering Technologies Inc Pipeline Products Overview 10
Contact Lens 10
Contact Lens Product Overview 10
Intraocular Lens 11
Intraocular Lens Product Overview 11
NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses 12
NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses Product Overview 12
NaturalVue Toric 1 Day Contact Lenses 13
NaturalVue Toric 1 Day Contact Lenses Product Overview 13
NaturalVue Toric Multifocal 1 Day Contact Lenses 14
NaturalVue Toric Multifocal 1 Day Contact Lenses Product Overview 14
VTI MPC Lens 15
VTI MPC Lens Product Overview 15
Visioneering Technologies Inc - Key Competitors 16
Visioneering Technologies Inc - Key Employees 17
Visioneering Technologies Inc - Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Visioneering Technologies Inc, Recent Developments 19
Jun 22, 2018: Visioneering Technologies Unveils NaturalVue Sphere with Comfort Enhancers at American Optometric Association Meeting 19
Mar 02, 2018: Visioneering Technologies Receives Regulatory Approval from Australias Therapeutic Good Administration (TGA) for its NaturalVue Family of 1 Day Contact Lenses 19
Jan 31, 2018: Visioneering Technologies Achieves CE Mark for NaturalVue Family of 1 Day Contact Lenses 20
Jan 31, 2018: Ferrings ZOMACTON (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficiency in Adults 20
Jan 28, 2018: Newly Expanded Evidence from Clinical Practice on NaturalVue (etafilcon A) 1 Day Contact Lenses for Paediatric Myopia Highlighted at the Global Specialty Lens Symposium 21
Jan 21, 2018: Visioneering Technologies Appendix 4C and Cash Flow Report 22
Jan 04, 2018: Courtney Hoverson to Lead Territory Management Efforts for NaturalVue Contact Lenses in Phoenix 22
Dec 19, 2017: Visioneering Technologies Welcomes Senior Life Sciences Executive Jean Franchi to its Board of Directors 23
Dec 14, 2017: Visioneering Technologies Names Heather Hale as Company Controller 23
Nov 16, 2017: David K. Denton Joins VTI Team as Territory Manager for Houston 23
Appendix 25
Methodology 25
About GlobalData 28
Contact Us 28
Disclaimer 28

List Of Tables


Visioneering Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Visioneering Technologies Inc Pipeline Products by Equipment Type 5
Visioneering Technologies Inc Pipeline Products by Indication 5
Visioneering Technologies Inc, Key Facts 6
Visioneering Technologies Inc, Major Products and Services 7
Visioneering Technologies Inc Number of Pipeline Products by Development Stage 8
Visioneering Technologies Inc Pipeline Products Summary by Development Stage 9
Contact Lens - Product Status 10
Contact Lens - Product Description 10
Intraocular Lens - Product Status 11
Intraocular Lens - Product Description 11
NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses - Product Status 12
NaturalVue (etafilcon A) Sphere 1 Day Contact Lenses - Product Description 12
NaturalVue Toric 1 Day Contact Lenses - Product Status 13
NaturalVue Toric 1 Day Contact Lenses - Product Description 13
NaturalVue Toric Multifocal 1 Day Contact Lenses - Product Status 14
NaturalVue Toric Multifocal 1 Day Contact Lenses - Product Description 14
VTI MPC Lens - Product Status 15
VTI MPC Lens - Product Description 15
Visioneering Technologies Inc, Key Employees 17
Glossary 27

List Of Figures


Visioneering Technologies Inc Pipeline Products by Equipment Type 5
Visioneering Technologies Inc Pipeline Products by Development Stage 8

Visioneering Technologies Inc (VTI) - Product Pipeline Analysis, 2018 Update

Visioneering Technologies Inc (VTI) is a medical device company that offers ophthalmic solutions. The company develops a portfolio of technologies to address eye care issues such as presbyopia, myopia and

USD 750View Report

Visioneering Technologies Inc - Product Pipeline Analysis, 2017 Update

Visioneering Technologies Inc (VTI) is a medical device company that develops and commercializes on-eye and in-eye solutions for presbyopia, astigmatism and myopia progression control. The company offers technology consists of

USD 750View Report

Sentien Biotechnologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sentien Biotechnologies Inc (Sentien) is a clinical stage biotechnology company that develops novel delivery approaches to cell therapy. The companys lead product SBI-101 is used for the treatment of patients

USD 250View Report

Hoverink Biotechnologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hoverink Biotechnologies Inc (Hoverink) formerly Hoverink International Holdings Inc, is a preclinical biopharmaceutical company that discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 750
  • Site Licence    USD 1500
  • Enterprise Wide Licence    USD 2250
$ 750

Reports Details

Published Date : Jul 2018
No. of Pages :28
Country :United States of America
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube